Managing Multiple Sclerosis

Archive for the ‘Multiple Sclerosis Treatments’ Category

Wow! Now this is exciting! If you suffer from multiple sclerosis or know someone who does, this is the kind of news we’ve been waiting to hear! According to this article Accentia Drug First Aimed at ‘Curing’ MS, which was published by United Press International, Accentia Biopharmaceuticals is planning to seek permission from the FDA for Phase 3 trials of its new drug Revimmune. According to the article, studies done at Johns Hopkins University School of Medicine showed a 42% average improvement in function in those patients, with Relapsing Remitting Multiple Sclerosis (RRMS). Accentia says that the investigational drug "holds the potential to restore function in many patients who have accute deficits due to MS". With the recent story on genes being connected to MS being found, and now this, MS research seems to be taking a big jump forward lately. Hopefully, this is the type of research that we’ve been hoping for! — Vince